title: A case of cholesterosis bulbi with secondary glaucoma treated by vitrectomy and intravitreal bevacizumab.
abstract: We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history of long-standing retinal detachment in his right eye after the irrigation and aspiration of a congenital cataract, presented with a clinical picture of elevated intraocular pressure and ocular pain. Upon slit-lamp examination, we found a ciliary injection and a pseudohypopyon of polychromatic crystals. Gonioscopic examination revealed a large amount of crystals deposited on the trabecular meshwork and mild rubeosis iridis, but the neovascularization of the angle could not be clearly confirmed due to the presence of so many crystals. Pars plana vitrectomy was performed to remove clusters of crystals and bevacizumab was injected intravitreally to treat iris neovascularization. Aqueous aspirate was examined by light microscopy and the typical highly refringent cholesterol crystals were identified. Intraocular pressure returned to a normal level after the bevacizumab injection, although severe cholesterosis was still evident in the anterior chamber. To our knowledge, this would be the first Korean case of cholesterosis bulbi combined with chronic retinal detachment and presumed neovascular glaucoma, which was treated by pars plana vitrectomy and intravitreal bevacizumab injection.
authors: Department of Ophthalmology, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea.
authors: Jongseok
authors: J
authors: Park
authors: Hoyoung
authors: H
authors: Lee
authors: Young Kook
authors: YK
authors: Kim
authors: Jeong Don
authors: JD
authors: Chae
authors: Hyun Joo
authors: HJ
authors: Lee
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000867:Anterior Chamber / Q000378:metabolism*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D002784:Cholesterol; D005128:Eye Diseases / Q000150:complications / Q000378:metabolism; D005500:Follow-Up Studies; D005901:Glaucoma / Q000601:surgery; D015355:Glaucoma, Neovascular / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D014821:Vitrectomy / Q000379:methods*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002784:Cholesterol